Wu S - Search Results

1

Different effects of three interferons L on Toll-like receptor-related gene expression in HepG2 cells.

Kanda T, Jiang X, Nakamoto S, Nakamura M, Miyamura T, Wu S, Yokosuka O. Kanda T, et al. Among authors: wu s. Cytokine. 2013 Nov;64(2):577-83. doi: 10.1016/j.cyto.2013.08.010. Epub 2013 Sep 13. Cytokine. 2013. PMID: 24041672

2

Hepatitis B virus e antigen downregulates cytokine production in human hepatoma cell lines.

Wu S, Kanda T, Imazeki F, Arai M, Yonemitsu Y, Nakamoto S, Fujiwara K, Fukai K, Nomura F, Yokosuka O. Wu S, et al. Viral Immunol. 2010 Oct;23(5):467-76. doi: 10.1089/vim.2010.0042. Viral Immunol. 2010. PMID: 20883161

3

Initial virological response and viral mutation with adefovir dipivoxil added to ongoing Lamivudine therapy in Lamivudine-resistant chronic hepatitis B.

Wu S, Fukai K, Imazeki F, Arai M, Kanda T, Yonemitsu Y, Yokosuka O. Wu S, et al. Dig Dis Sci. 2011 Apr;56(4):1207-14. doi: 10.1007/s10620-010-1423-y. Epub 2010 Oct 7. Dig Dis Sci. 2011. PMID: 20927588

4

Simple assay based on restriction fragment length polymorphism associated with IL28B in chronic hepatitis C patients.

Nakamoto S, Kanda T, Imazeki F, Wu S, Arai M, Fujiwara K, Yokosuka O. Nakamoto S, et al. Among authors: wu s. Scand J Gastroenterol. 2011 Jul;46(7-8):955-61. doi: 10.3109/00365521.2011.574731. Scand J Gastroenterol. 2011. PMID: 21529139

5

Response to peginterferon-alfa 2b and ribavirin in Japanese patients with chronic hepatitis C genotype 2.

Kanda T, Imazeki F, Azemoto R, Yonemitsu Y, Mikami S, Kita K, Takashi M, Sunaga M, Wu S, Nakamoto S, Tawada A, Arai M, Kato K, Yoshida Y, Koma Y, Fujiwara K, Fukai K, Suzuki N, Yokosuka O. Kanda T, et al. Among authors: wu s. Dig Dis Sci. 2011 Nov;56(11):3335-42. doi: 10.1007/s10620-011-1750-7. Epub 2011 May 22. Dig Dis Sci. 2011. PMID: 21604145

6

Emergence of entecavir-resistant mutations in nucleos(t)ide-naive Japanese patients infected with hepatitis B virus: virological breakthrough is also dependent on adherence to medication.

Kamezaki H, Kanda T, Wu S, Nakamoto S, Arai M, Maruyama H, Fujiwara K, Imazeki F, Yokosuka O. Kamezaki H, et al. Among authors: wu s. Scand J Gastroenterol. 2011 Sep;46(9):1111-7. doi: 10.3109/00365521.2011.584898. Epub 2011 May 30. Scand J Gastroenterol. 2011. PMID: 21623676

7

Epigenetic silencing of microRNA-373 plays an important role in regulating cell proliferation in colon cancer.

Tanaka T, Arai M, Wu S, Kanda T, Miyauchi H, Imazeki F, Matsubara H, Yokosuka O. Tanaka T, et al. Among authors: wu s. Oncol Rep. 2011 Nov;26(5):1329-35. doi: 10.3892/or.2011.1401. Epub 2011 Jul 22. Oncol Rep. 2011. PMID: 21785829

8

Hepatitis C Virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of Toll-like receptor 4.

Tamura R, Kanda T, Imazeki F, Wu S, Nakamoto S, Tanaka T, Arai M, Fujiwara K, Saito K, Roger T, Wakita T, Shirasawa H, Yokosuka O. Tamura R, et al. Among authors: wu s. J Infect Dis. 2011 Sep 1;204(5):793-801. doi: 10.1093/infdis/jir381. J Infect Dis. 2011. PMID: 21844306

9

Nuclear receptor mRNA expression by HBV in human hepatoblastoma cell lines.

Wu S, Kanda T, Imazeki F, Nakamoto S, Shirasawa H, Yokosuka O. Wu S, et al. Cancer Lett. 2011 Dec 15;312(1):33-42. doi: 10.1016/j.canlet.2011.07.025. Epub 2011 Aug 22. Cancer Lett. 2011. PMID: 21903321

10

Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients.

Miyamura T, Kanda T, Nakamoto S, Wu S, Fujiwara K, Imazeki F, Yokosuka O. Miyamura T, et al. Among authors: wu s. PLoS One. 2011;6(12):e28617. doi: 10.1371/journal.pone.0028617. Epub 2011 Dec 12. PLoS One. 2011. PMID: 22174846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results